By Zachary Zagger ( April 16, 2015, 9:32 PM EDT) -- Late-stage biotech company KemPharm Inc. stumbled in its initial public offering Wednesday, raising $56 million after pricing shares below their expected range but selling additional shares to hit its target raise amid a flurry of biotech IPO activity this week....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.